Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Kleanthous

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Vaccine|March 26, 2019
A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strainsTed M Ross, Joshua DiNapoli, Maryann Giel-Moloney, et al.
Nature Communications|August 24, 2023
Antibody-mediated NK cell activation as a correlate of immunity against influenza infectionCarolyn M Boudreau, John S Burke, Ashraf S Yousif, et al.
Journal of Virology|September 7, 2018
Development of a Pan-H1 Influenza VaccineNicole Darricarrère, Svetlana Pougatcheva, Xiaochu Duan, et al.
Clinical and Vaccine Immunology : CVI|May 1, 2015
A Combination of Three Fully Human Toxin A- and Toxin B-Specific Monoclonal Antibodies Protects against Challenge with Highly Virulent Epidemic Strains of Clostridium difficile in the Hamster ModelNatalie G Anosova, Leah E Cole, Lu Li, et al.
Plos One|October 17, 2012
Immunogenicity and efficacy of intramuscular replication-defective and subunit vaccines against herpes simplex virus type 2 in the mouse genital modelSimon Delagrave, Hector Hernandez, Changhong Zhou, et al.
Vaccine|August 6, 2017
Incorporation of RG1 epitope concatemers into a self-adjuvanting Flagellin-L2 vaccine broaden durable protection against cutaneous challenge with diverse human papillomavirus genotypesKirill Kalnin, Sudha Chivukula, Timothy Tibbitts, et al.
Human Vaccines & Immunotherapeutics|November 6, 2023
Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor-binding domain (RBD)Ozan S Kumru, Sakshi Bajoria, Kawaljit Kaur, et al.
Vaccines|June 28, 2023
Nanoalum Formulations Containing Aluminum Hydroxide and CpG 1018<sup>TM</sup> Adjuvants: The Effect on Stability and Immunogenicity of a Recombinant SARS-CoV-2 RBD AntigenSakshi Bajoria, Ozan S Kumru, Jennifer Doering, et al.
Current Research in Structural Biology|April 26, 2022
Novel structural insights for a pair of monoclonal antibodies recognizing non-overlapping epitopes of the glucosyltransferase domain of <i>Clostridium difficile</i> toxin BJinyu Liu, Michael Kothe, Jianxin Zhang, et al.
Vaccine|August 7, 2019
Corrigendum to "A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strains" [Vaccine 37 (2019) 2369-2376]Ted M Ross, Joshua DiNapoli, Maryann Giel-Moloney, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Vaccine|March 26, 2019
A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strainsTed M Ross, Joshua DiNapoli, Maryann Giel-Moloney, et al.
Nature Communications|August 24, 2023
Antibody-mediated NK cell activation as a correlate of immunity against influenza infectionCarolyn M Boudreau, John S Burke, Ashraf S Yousif, et al.
Journal of Virology|September 7, 2018
Development of a Pan-H1 Influenza VaccineNicole Darricarrère, Svetlana Pougatcheva, Xiaochu Duan, et al.
Clinical and Vaccine Immunology : CVI|May 1, 2015
A Combination of Three Fully Human Toxin A- and Toxin B-Specific Monoclonal Antibodies Protects against Challenge with Highly Virulent Epidemic Strains of Clostridium difficile in the Hamster ModelNatalie G Anosova, Leah E Cole, Lu Li, et al.
Plos One|October 17, 2012
Immunogenicity and efficacy of intramuscular replication-defective and subunit vaccines against herpes simplex virus type 2 in the mouse genital modelSimon Delagrave, Hector Hernandez, Changhong Zhou, et al.
Vaccine|August 6, 2017
Incorporation of RG1 epitope concatemers into a self-adjuvanting Flagellin-L2 vaccine broaden durable protection against cutaneous challenge with diverse human papillomavirus genotypesKirill Kalnin, Sudha Chivukula, Timothy Tibbitts, et al.
Human Vaccines & Immunotherapeutics|November 6, 2023
Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor-binding domain (RBD)Ozan S Kumru, Sakshi Bajoria, Kawaljit Kaur, et al.
Vaccines|June 28, 2023
Nanoalum Formulations Containing Aluminum Hydroxide and CpG 1018<sup>TM</sup> Adjuvants: The Effect on Stability and Immunogenicity of a Recombinant SARS-CoV-2 RBD AntigenSakshi Bajoria, Ozan S Kumru, Jennifer Doering, et al.
Current Research in Structural Biology|April 26, 2022
Novel structural insights for a pair of monoclonal antibodies recognizing non-overlapping epitopes of the glucosyltransferase domain of <i>Clostridium difficile</i> toxin BJinyu Liu, Michael Kothe, Jianxin Zhang, et al.
Vaccine|August 7, 2019
Corrigendum to "A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strains" [Vaccine 37 (2019) 2369-2376]Ted M Ross, Joshua DiNapoli, Maryann Giel-Moloney, et al.
Pageof 6